A Japanese court ruled that an order for restaurant chain operator Global-Dining Inc. to reduce business hours amid the coronavirus pandemic was illegal, as it did not fulfill certain conditions.
Presiding Judge Norihiro Matsuda stated in his decision that it is difficult to acknowledge that Global-Dining enhanced the chance of the virus spreading throughout the community.
He further claimed that because the directive was issued just days before the state of emergency was removed, it had "just a little influence on infection management."
The metropolitan government claims that Global-Dining's commnets on its website caused other eateries to be hesitant to comply with the decree. The court, however, disagreed.
Global-Dining, on the other hand, claims that imposing blanket limits without providing evidence that restaurants are a source of illnesses is a violation of the Constitutional right of corporate freedom.
The firm, which owns and operates dozens of eateries, promptly filed an appeal.


SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Federal Judge Blocks Trump Administration Move to End TPS for Haitian Immigrants
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Trump Lawsuit Against JPMorgan Signals Rising Tensions Between Wall Street and the White House
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 



